According to BELLUS Health's latest financial reports the company's current EPS (TTM) is -$0.71. In 2022 the company made an earnings per share (EPS) of -$0.66 an increase over its 2021 EPS that were of -$0.90.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.71 | 7.58% |
2022 | -$0.66 | -26.67% |
2021 | -$0.90 | 66.67% |
2020 | -$0.54 | -1.82% |
2019 | -$0.55 | 277.94% |
2018 | -$0.15 | 113.17% |
2017 | -$0.06827 | -14.4% |
2016 | -$0.07975 | -1101.25% |
2015 | $0.007965 | -107.45% |
2014 | -$0.11 | 68.27% |
2013 | -$0.06352 | -95.74% |
2012 | -$1.49 | -210.77% |
2011 | $1.35 | -110.39% |
2010 | -$12.96 | 120.4% |
2009 | -$5.88 | -93.17% |
2008 | -$86.16 | -56.93% |
2007 | -$200.06 | -250.02% |
2006 | $133.35 | -5.26% |
2005 | $140.76 | 29.59% |
2004 | $108.63 | -367.71% |
2003 | -$40.58 | 3.91% |
2002 | -$39.05 | 399.01% |
2001 | -$7.83 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 207.04% | ๐บ๐ธ USA |